APMGR: Over 2,000 drugs at risk of disappearing from the market due to clawback tax

Georgiana Bendre 14/07/2017 | 11:35

The Association of Generic Medical Drugs from Romania (APMGR) warns about the risk of disappearance of over 2,000 drugs from the market due to clawback tax that aims to increase to 30 percent. APMGR requests the differentiated computation of the clawback tax this year and the elimination of tax for generic drugs from 2018.

“The clawback tax is a tax on turnover for drugs producers and no company can survive much time with its level close to 30 percent. This means the destruction of local pharma market and the disappearance of some essential drugs for million of patients, especially for the chronic patients,” said Adrian Grecu, president of APMGR.

In the first quarter of this year, the clawback tax reached almost 20 percent and the APMGR estimates that in the second quarter it will be 25 percent and until the end of the year, it can exceed 30 percent. The tax is growing due to the introduction of new molecules in an unconditional manner on the subsidized drugs list, without an additional budget, to which is added the diminishment of the ceiling for pensioners, as well as the special commissions that checked the validity of prescriptions.

From 2016 until April 2017, authorities added 42 new molecules on the subsidized drugs list, requiring annual additional costs of around EUR 70 million.

BR Magazine | Latest Issue

Download PDF or read online: March 2023 Issue | Business Review Magazine

The March 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “25 Leaders to Watch in 2023.” Read it online by clicking here. To
Georgiana Bendre | 09/03/2023 | 17:26

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of business-review.eu

    I agree with the storage and handling of my data by business-review.eu

    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue